Johnson and Johnson exploring sale of diabetes segment

US-based group Johnson & Johnson is reportedly exploring the sale of its Diabetes Care segment, including the brands LifeScan, Animas and Calibra, blood glucose meters and insulin pumps, which have generated a total sales volume of approximately $1.8bn (2016). The news was announced simultaneously with the 2016 Q4 results publication. (Source J&J)